Where does Speclipse, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Speclipse, Inc. ranks #25,265 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Speclipse, Inc. hold?

Speclipse, Inc. holds 11 US utility patents granted between 2018 and 2025, spanning 13 technology areas.

What is Speclipse, Inc.'s Innovation Score?

Speclipse, Inc. has an Innovation Score of 33.9 out of 100 (46th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Speclipse, Inc. focus on?

Speclipse, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 8 patents, ranking #2,086 of 7,127 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Speclipse, Inc.'s patent grant rate increasing or decreasing?

Speclipse, Inc.'s recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Speclipse, Inc.'s patents?

Speclipse, Inc.'s patents average 12.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Speclipse, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Speclipse, Inc.

USPTO PatentsView assignee record - 11 granted patents across 13 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Speclipse ranks #25,265 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 13 technology areas.

#25,265
of 49,997 US assignees by volume: 46th percentile
by Innovation Score (33.9/100): 12.1
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25265 · Foreign Corporation #25,265 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #25,265/49,997
PHOTO-FINISH Solaris Oilfield…
CPC-FOCUS A61B · 13 areas
INNOV-THIN 33.9/100
CLAIMS-RICH 12.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Solaris Oilfield Site Services Operating LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Speclipse’s 33.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (25%) Velocity 5.3 pts (16%) Breadth 12.7 pts (37%) Claim depth 7.3 pts (22%)

Qualcomm Incorporated · highest

85
Speclipse · this assignee

34
3D Lighting… · lowest

7

What this shows Speclipse's Innovation Score is 33.9/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Speclipse?

Each dot is one of Speclipse’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Speclipse’s own 12.1 claims/patent is at or below the 17.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Speclipse vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Speclipse's grants concentrate

Speclipse, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 72.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2018. By volume, Speclipse sits between Solaris Oilfield Site Services Operating LLC and Spruce Biosciences, Inc..

Speclipse's three-year grant acceleration

Speclipse, Inc. shows 4 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Solaris Oilfield…

11
Solvay Solexis S…

11
Sondex Wireline

11
Specialized Desan…

11
Spectrum Optix

11
SPF

11
Spinefrontier

11
Spruce Biosciences

11
Speclipse ◀

11

What this shows Speclipse holds 11 patents at rank #25,179, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Speclipse

By rank, the assignees closest to #25,179 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Speclipse's primary technology class.

Speclipse's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 46th percentile higher than 46% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Speclipse, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	9.1%
2019	3	27.3%
2020	1	9.1%
2021	1	9.1%
2022	2	18.2%
2023	1	9.1%
2024	1	9.1%
2025partial year	1	9.1%

Which technologies does Speclipse, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 8

G01J - Measurement OF Intensity, Velocity, Spectral Content, Polarisation, Phase OR Pulse Characteristics OF Infrared, Visible OR Ultraviolet LIGHT; COLORIMETRY; Radiation Pyrometry 7

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

B63B - Ships OR Other Waterborne VESSELS; Equipment FOR Shipping 4

F02M - Supplying Combustion Engines IN General With Combustible Mixtures OR Constituents Thereof 4

Y02T - Climate Change Mitigation Technologies Related TO Transportation 4

B63J - Auxiliaries ON Vessels 4

F17C - Vessels FOR Containing OR Storing Compressed, Liquefied OR Solidified GASES; Fixed-capacity GAS-HOLDERS; Filling Vessels With, OR Discharging From Vessels, Compressed, Liquefied, OR Solidified Gases 4

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

G06N - Computing Arrangements Based ON Specific Computational Models 1

G06T - Image Data Processing OR Generation, IN General 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

G02B - Optical Elements, Systems OR Apparatus 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Speclipse, Inc.'s patent record in context - here's where to go next.

Speclipse, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 72.7% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #25,265 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Speclipse, Inc. against Solaris Oilfield Site Services Operating LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.